Results 1 to 10 of about 11,802 (200)

Carbapenem resistant Enterobacterales in the United Arab Emirates: a retrospective analysis from 2010 to 2021 [PDF]

Frontiers in Public Health, 2023
BackgroundCarbapenem-resistant Enterobacterales (CRE) are spreading in the United Arab Emirates (UAE) where their dissemination is facilitated by international travel, trade, and tourism.
Jens Thomsen, Jens Thomsen, Najiba M. Abdulrazzaq, The UAE AMR Surveillance Consortium, Dean B. Everett, Dean B. Everett, Dean B. Everett, Godfred Antony Menezes, Abiola Senok, Abiola Senok, Carole Ayoub Moubareck   +10 more
doaj   +6 more sources

Comparison of Three Phenotypic Methods of Carbapenemase Enzyme Detection to Identify Carbapenem-resistant Enterobacterales

Journal of Pure and Applied Microbiology, 2022
The prevalence of multidrug-resistant gram-negative bacilli has increased worldwide. Critical care areas of most hospitals use carbapenem antibiotics for the empirical treatment of gram-negative bacterial (GNB) infections.
Amisha Piyush Khare, Anusha Gopinathan, K.V. Leela, Shweta Naik   +3 more
doaj   +3 more sources

Systematic Analysis of Mobile Genetic Elements Mediating β-Lactamase Gene Amplification in Noncarbapenemase-Producing Carbapenem-Resistant Enterobacterales Bloodstream Infections

mSystems, 2022
Noncarbapenemase-producing carbapenem-resistant Enterobacterales (non-CP-CRE) are increasingly recognized as important contributors to prevalent carbapenem-resistant Enterobacterales (CRE) infections. However, there is limited understanding of mechanisms
W. C. Shropshire, A. Konovalova, P. McDaneld, M. Gohel, B. Strope, P. Sahasrabhojane, C. N. Tran, D. Greenberg, J. Kim, X. Zhan, S. Aitken, M. Bhatti, T. C. Savidge, T. J. Treangen, B. M. Hanson, C. A. Arias, S. A. Shelburne   +16 more
doaj   +2 more sources

Screening for Fosfomycin Resistance Genes in Carbapenem- Resistant Isolates of Enterobacterales from the Bloodstream of Liver Transplant Patients

Mediterranean Journal of Infection, Microbes and Antimicrobials, 2022
Introduction: Interest in fosfomycin, an old antibiotic, has been reignited because of the use of its intravenous formulation (fosfomycin sodium) in resistant infections.
Yakup GEZER, Elif Seren TANRIVERDİ, Barış OTLU, Sezai YILMAZ, Yaşar BAYINDIR   +4 more
doaj   +2 more sources

Investigation of New Delhi metallo-beta-lactamase-1 (blandm-1) gene in carbapenem-resistant Enterobacterales strains isolated from a university hospital in Turkey

Medicine Science, 2021
In this study, the presence of blaNDM-1 gene in carbapenem-resistant Enterobacterales obtained from various clinical specimen of a University Hospital in Turkey between the years 2014-2019, has been investigated.
Merih Simsek, Cengiz Demir, Esra Seker
doaj   +2 more sources

High prevalence of bla NDM gene among a series of carbapenem-resistant Enterobacterales isolates from children less than one year old in Niger [PDF]

BMC Microbiology
Background Carbapenem-resistant Enterobacterales are increasingly reported worldwide, posing significant treatment challenges, especially in vulnerable pediatric populations.
Issoufou Noma Massir, Yacouba Abdourahamane, Tapha Ounoussa, Hamidou Oumou, Ousmane Abdoulaye, Aminatou Ousmane, Moussa Harouna, Brah Souleymane, Mahamadou Doutchi, Mamadou Saidou, Ibrahim Mamane Laminou   +10 more
doaj   +2 more sources

Prevalence of Carbapenem-Resistant Enterobacterales, Acinetobacter baumannii, and Pseudomonas aeruginosa in a Tertiary Care Hospital in Eastern India: A Pilot Study

Journal of Pure and Applied Microbiology, 2023
In recent years, a wide range of clinical infections are being caused by carbapenem-resistant Enterobacterales, Acinetobacter baumannii and Pseudomonas aeruginosa. This is a matter of great concern, as carbapenem-resistant infections have fewer treatment
Gaurav Verma, Subham Ravi Nayak, Swetapadma Jena, Subhra Snigdha Panda, Dipti Pattnaik, A.K. Praharaj, Nipa Singh   +6 more
doaj   +1 more source

In vitro activity of ceftazidime/avibactam against Gram-negative strains in Colombia 2014–2018

Journal of Global Antimicrobial Resistance, 2022
: Objectives: Ceftazidime/avibactam (CAZ/AVI) has shown in vitro activity against multidrug-resistant (MDR) Gram-negative bacteria, especially Enterobacterales and carbapenem-resistant Pseudomonas aeruginosa.
Elkin V. Lemos-Luengas, MD, PhD, Sixta Rentería-Valoyes, MD, Paola Cárdenas-Isaza, MD, MSc, Jorge A. Ramos-Castaneda, PhD   +3 more
doaj   +1 more source

In Vitro Activity of New β-Lactam–β-Lactamase Inhibitor Combinations and Comparators against Clinical Isolates of Gram-Negative Bacilli: Results from the China Antimicrobial Surveillance Network (CHINET) in 2019

Microbiology Spectrum, 2022
Novel β-lactam–β-lactamase inhibitor combinations (BLBLIs) are in clinical development for the treatment of infections caused by carbapenem-resistant and difficult-to-treat resistant (DTR) (defined as resistance to all tested β-lactams and ...
Yan Guo, Renru Han, Bo Jiang, Li Ding, Fengzhen Yang, Beijia Zheng, Yang Yang, Shi Wu, Dandan Yin, Demei Zhu, Fupin Hu   +10 more
doaj   +1 more source

Replacement of the Double Meropenem Disc Test with a Lateral Flow Assay for the Detection of Carbapenemase-Producing Enterobacterales and Pseudomonas aeruginosa in Clinical Laboratory Practice

Antibiotics, 2023
The prompt detection of carbapenemases among Gram-negative bacteria isolated from patients’ clinical infection samples and surveillance cultures is important for the implementation of infection control measures.
Areti Tychala, Georgios Meletis, Paraskevi Mantzana, Angeliki Kassomenaki, Charikleia Katsanou, Aikaterini Daviti, Lydia Kouroudi, Lemonia Skoura, Efthymia Protonotariou   +8 more
doaj   +1 more source